logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

New Stock News | Jingxin Pharmaceutical (002020.SZ) Files Again with HKEX, Has Successfully Launched Class 1 Innovative Drug Dimdazenil

date
19/09/2026
Zhito Finance APP has learned that according to a disclosure by the Hong Kong Stock Exchange on September 18, Zhejiang Jingxin Pharmaceutical Co., Ltd. (referred to as: Jingxin Pharmaceutical, 002020.SZ) has once again submitted an application for listing to the Main Board of the Hong Kong Stock Exchange, with CITIC Securities as its sole sponsor.
Latest
36 m ago
New Stock News | Jingxin Pharmaceutical (002020.SZ) Files Again with HKEX, Has Successfully Launched Class 1 Innovative Drug Dimdazenil
1 h ago
Recently, BlackRock Fund obtained Qualified Domestic Institutional Investor (QDII) status, becoming the first newly established foreign-funded public fund manager to receive such status. Against the backdrop of two expansions of QDII quotas this year and securities fund institutions' approved quotas exceeding $100 billion for the first time, foreign-funded public fund managers are accelerating their participation in the cross-border investment market. Since the beginning of this year, the pace of QDII channel expansion has notably accelerated. Data released by the State Administration of Foreign Exchange at the end of March showed that the cumulative approved QDII quota across the market increased by $5.3 billion from the end of 2025, reaching $176.169 billion. At the end of August, SAFE granted another $6.84 billion in QDII quotas, involving 89 institutions. As of the end of August, the cumulative approved QDII quota for 196 institutions across the market rose to $183.009 billion. (Securities Times).
1 h ago
New Stock News | Jingxin Pharmaceutical (002020.SZ) Files Again with the Hong Kong Stock Exchange
1 h ago
On September 19, the 2026 New Cornerstone 50 Forum, hosted by Tencent's Sustainable Social Value (SSV) business unit, the New Cornerstone Science Foundation, and the Southern University of Science and Technology, was held in Shenzhen. Xi Dan, Senior Vice President and Chief Talent Officer of Tencent, said at the meeting that Tencent's determination to support basic scientific research will not change, and this is also Tencent's long-term commitment beyond commercial boundaries. Xi Dan believes that today's scientific research is advancing toward various boundaries of human cognition and has far exceeded any single discipline. The interdisciplinary integration and the impact of artificial intelligence on scientific research are becoming sources of technological innovation. (21 Finance).
2 h ago
Cui Dongshu: Auto exports reached $129.1 billion in Jan-Aug, up 53%; Chinese automakers are highly dynamic.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.